iShares US Pharmaceuticals ETF
IHE
IHE
63 hedge funds and large institutions have $157M invested in iShares US Pharmaceuticals ETF in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
5% less capital invested
Capital invested by funds: $164M → $157M (-$7.67M)
12.55% less ownership
Funds ownership: 107.64% → 95.09% (-13%)
Holders
63
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.97M | |
| 2 | +$1.88M | |
| 3 | +$844K | |
| 4 |
SG Americas Securities
New York
|
+$756K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$416K |
Top Sellers
| 1 | -$9.83M | |
| 2 | -$6.13M | |
| 3 | -$5.77M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.74M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.85M |